Dividend compounder review
SCLP
Scancell Holdings plc · LSE · GB
Healthcare · Biotechnology
Score26.00/100
Confidence67.00/100
DecisionInsufficient Data
RatingAvoid
Quality breakdown
Dividend Reliability
0.0 / 25
Payment history, cuts, growth, and regularity.
Dividend Sustainability
7.0 / 20
Payout, free cash flow, dividend cover, and debt.
Business Quality
8.0 / 25
Scale, cash generation, growth, margins, and returns.
Valuation Discipline
1.0 / 15
Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend
10.0 / 15
Trend line, long return history, and drawdown control.
Dividend and business context
Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income£-5.9M
Free Cash Flow£-15.8M
FCF Covers DividendUnknown
Debt / Equity-
P/E-
Revenue Growth 5Y-
Net Margin-117.0%
ROE-
Price vs Trend41.6%
3Y Return45.6%
5Y Return-12.3%
CurrencyGBP
Review flags
No usable dividend history found.
Free cash flow is negative.
Activity record
Free cash flow is negative.